The Chinese University of Hong Kong & Prince of Wales Hospital

Department of Obstetrics and Gynaecology

CHUK Facebook icon CHUK Instagram icon CHUK Twitter icon CHUK Youtube icon

Prof. Poon Chiu Yee, Liona

Prof. Poon Chiu Yee, Liona Department Chairperson & Professor (Clinical), Co-Team Head for Maternal Medicine
(852) 3505 2806 liona.poon@cuhk.edu.hk

Qualifications

FHKCOG, FHKAM (Obstetrics and Gynaecology) ,MBBS (University of London), MRCOG, MD(Res) (University of London), Cert RCOG (Maternal and Fetal Medicine)

Biography

Prof. Liona Poon is the Chairperson of Obstetrics and Gynecology and an Academic Subspecialist in Maternal Fetal Medicine at the Chinese University of Hong Kong, Hong Kong SAR China, and Visiting Professor at the Department of Women and Children’s Health, King’s College London, London, UK. She is devoted in improving maternal and fetal health. She has had a prolific research output throughout her clinical and research posts, including >250 peer-reviewed publications in high impact international journals (H-index 60). In the last 15 years she has focused her research on establishing a programme for effective early prediction and prevention of preeclampsia, a major cause of maternal and perinatal morbidity and mortality. With her success in developing a first-trimester prediction model for preeclampsia using maternal risk factors, ultrasound, blood pressure and biochemical markers, and on Aspirin prophylaxis against preeclampsia, her goal in the next 10 years is to improve obstetric care worldwide, through clinical research, education and advocacy. 

Research Interests

Her main research interests are in the prediction and prevention of maternal and perinatal morbidity and mortality. These include developing screening models for the prediction of aneuploidies, preeclampsia, fetal growth restriction, gestational diabetes, macrosomia, stillbirth, spontaneous preterm birth and induced labour. She is experienced in conducting large-scale multicentre prospective cohort studies and randomised trials.

Grants

EC FP7 (601852-2), NIHR EME (14/01/02), NIHR HTA (14/158), CUHK Start-up Support Fund, HK O&G Trust Fund, ITF (ITS/252/17FX), HMRF (18190821, 6906043, 07181186, 07181186) and MOST (2021YFC2701600)

1
Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis Smith ER, Oakley E, Grandner GW, Rukundo G, Farooq F, Ferguson K, Baumann S, Adams Waldorf KM, Afshar Y, Ahlberg M, Ahmadzia H, Akelo V, Aldrovandi G, Bevilacqua E, Bracero N, Brandt JS, Broutet N, Carrillo J, Conry J, Cosmi E, Crispi F, Crovetto F, Del Mar Gil M, Delgado-López C, Divakar H, Driscoll AJ, Favre G, Fernandez Buhigas I, Flaherman V, Gale C, Godwin CL, Gottlieb S, Gratacós E, He S, Hernandez O, Jones S, Joshi S, Kalafat E, Khagayi S, Knight M, Kotloff KL, Lanzone A, Laurita Longo V, Le Doare K, Lees C, Litman E, Lokken EM, Madhi SA, Magee LA, Martinez-Portilla RJ, Metz TD, Miller ES, Money D, Moungmaithong S, Mullins E, Nachega JB, Nunes MC, Onyango D, Panchaud A, Poon LC, Raiten D, Regan L, Sahota D, Sakowicz A, Sanin-Blair J, Stephansson O, Temmerman M, Thorson A, Thwin SS, Tippett Barr BA, Tolosa JE, Tug N, Valencia-Prado M, Visentin S, von Dadelszen P, Whitehead C, Wood M, Yang H, Zavala R, Tielsch JM Am J Obstet Gynecol 2023 Feb;228(2):161-177
2
Maternal plasma diacylglycerols and triacylglycerols in the prediction of gestational diabetes mellitus Hou G, Gao Y, Poon LC, Ren Y, Zeng C, Wen B, Syngelaki A, Lin L, Zi J, Su F, Xie W, Chen F, Nicolaides KH BJOG. 2023 Feb;130(3):247-256
3
Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis Smith ER, Oakley E, Grandner GW, Ferguson K, Farooq F, Afshar Y, Ahlberg M, Ahmadzia H, Akelo V, Aldrovandi G, Tippett Barr BA, Bevilacqua E, Brandt JS, Broutet N, Fernández Buhigas I, Carrillo J, Clifton R, Conry J, Cosmi E, Crispi F, Crovetto F, Delgado-López C, Divakar H, Driscoll AJ, Favre G, Flaherman VJ, Gale C, Gil MM, Gottlieb SL, Gratacós E, Hernandez O, Jones S, Kalafat E, Khagayi S, Knight M, Kotloff K, Lanzone A, Le Doare K, Lees C, Litman E, Lokken EM, Laurita Longo V, Madhi SA, Magee LA, Martinez-Portilla RJ, McClure EM, Metz TD, Miller ES, Money D, Moungmaithong S, Mullins E, Nachega JB, Nunes MC, Onyango D, Panchaud A, Poon LC, Raiten D, Regan L, Rukundo G, Sahota D, Sakowicz A, Sanin-Blair J, Söderling J, Stephansson O, Temmerman M, Thorson A, Tolosa JE, Townson J, Valencia-Prado M, Visentin S, Von Dadelszen P, Adams Waldorf K, Whitehead C, Yassa M, Tielsch JM BMJ Glob Health. 2023 Jan;8(1):e009495
4
Hypertensive disorders of pregnancy and long-term cardiovascular health: FIGO Best Practice Advice Poon LC, Nguyen-Hoang L, Smith GN, Bergman L, O'Brien P, Hod M, Okong P, Kapur A, Maxwell CV, McIntyre HD, Jacobsson B, Algurjia E, Hanson MA, Rosser ML, Ma RC, O'Reilly SL, Regan L, Adam S, Medina VP, McAuliffe FM, FIGO Committee on Impact of Pregnancy on Long-term Health and the FIGO Division of Maternal and Newborn Health Int J Gynaecol Obstet. 2023 Jan;160 Suppl 1:22-34
5
ISUOG Practice Guidelines (updated): performance of 11–14-week ultrasound scan International Society of Ultrasound in Obstetrics and Gynecology, Bilardo CM, Chaoui R, Hyett JA, Kagan KO, Karim JN, Papageorghiou AT, Poon LC, Salomon LJ, Syngelaki A, Nicolaides KH Ultrasound Obstet Gynecol. 2023 Jan;61(1):127-143
6
Management of obesity across women's life course: FIGO Best Practice Advice Maxwell CV, Shirley R, O'Higgins AC, Rosser ML, O'Brien P, Hod M, O'Reilly SL, Medina VP, Smith GN, Hanson MA, Adam S, Ma RC, Kapur A, McIntyre HD, Jacobsson B, Poon LC, Bergman L, Regan L, Algurjia E, McAuliffe FM, FIGO Committee on Impact of Pregnancy on Long-term Health and the FIGO Division of Maternal and Newborn Health Int J Gynaecol Obstet. 2023 Jan;160 Suppl 1:35-49
7
Pregnancy as an opportunity to prevent type 2 diabetes mellitus: FIGO Best Practice Advice Adam S, McIntyre HD, Tsoi KY, Kapur A, Ma RC, Dias S, Okong P, Hod M, Poon LC, Smith GN, Bergman L, Algurjia E, O'Brien P, Medina VP, Maxwell CV, Regan L, Rosser ML, Jacobsson B, Hanson MA, O'Reilly SL, McAuliffe FM, FIGO Committee on the Impact of Pregnancy on Long-term Health and the FIGO Division of Maternal and Newborn Health Int J Gynaecol Obstet. 2023 Jan;160 Suppl 1:56-67
8
Risk factors for anxiety and depression among pregnant women during the COVID-19 pandemic: Results of a webbased multinational cross-sectional study Kajdy A, Sys D, Pokropek A, Shaw SW, Chang TY, Calda P, Acharya G, Ben-Zion M, Biron-Shental T, Borowski D, Czuba B, Etchegaray A, Feduniw S, Garcia-Mandujano R, Santacruz MG, Gil MM, Hassan S, Kwiatkowski S, Martin-Arias A, Martinez-Portilla RJ, Prefumo F, Rabijewski M, Salomon LJ, Tiller H, Verlohren S, Voon HY, Yanque-Robles OF, Yong SL, Poon LC , Mind-COVID Collaborative Team Int J Gynaecol Obstet. 2023 Jan;160(1):167-186
9
Using FIGO Nutrition Checklist counselling in pregnancy: A review to support healthcare professionals Killeen SL, Donnellan N, O'Reilly SL, Hanson MA, Rosser ML, Medina VP, Jacob CM, Divakar H, Hod M, Poon LC, Bergman L, O'Brien P, Kapur A, Jacobsson B, Maxwell CV, McIntyre HD, Regan L, Algurjia E, Ma RC, Adam S, McAuliffe FM, FIGO Committee on Impact of Pregnancy on Long-term Health and the FIGO Division of Maternal and Newborn Health Int J Gynaecol Obstet. 2023 Jan;160 Suppl 1:10-21
10
Uterine artery Doppler indices throughout gestation in women with and without previous Cesarean deliveries: a prospective longitudinal case-control study Yapan P, Tachawatcharapunya S, Surasereewong S, Thongkloung P, Pooliam J, Poon LC, Wataganara T Sci Rep. 2022 Dec 3;12(1):20913
11
Assessment of embryo morphology following perinatal exposure to aspirin, ibuprofen and paracetamol using whole embryo culture system Moungmaithong S, Leung BW, Sahota DS, Wang CC, Leung TY, Poon LC J Matern Fetal Neonatal Med. 2022 Dec;35(25):8786-8793
12
Genome-Wide Cell-Free DNA Test for Fetal Chromosomal Abnormalities and Variants: Unrestricted Versus Restricted Reporting Kwan AHW, Zhu X, Mar Gil M, Kwok YKY, Wah IYM, Hui ASY, Ting YH, Law KM, Lau D, Xue S, Choy KW, Sahota D, Leung TY, Poon LC Diagnostics (Basel). 2022 Oct 9;12(10):2439
13
SARS-CoV-2-specific antibodies and neutralization capacity in breast milk following infection vs vaccination Leung HYH, Leung BW, Gil MM, Rolle V, Moungmaithong S, Wang CC, Poon LC Ultrasound Obstet Gynecol. 2022 Sep;60(3):425-427
14
Screening for spontaneous preterm birth by cervical length and shear-wave elastography in the first trimester of pregnancy Feng Q, Chaemsaithong P, Duan H, Ju X, Appiah K, Shen L, Wang X, Tai Y, Leung TY, Poon LC Am J Obstet Gynecol. 2022 Sep;227(3):500.e1-500.e14
15
Effects of strict public health measures on seroprevalence of anti-SARS-CoV-2 antibodies during pregnancy Leung HHY, Kwok CYT, Sahota DS, Leung MBW, Lui GCY, Ng SSS, Leung WC, Chan PKS, Poon LCY Hong Kong Med J. 2022 Aug;28(4):294-299
16
First Trimester Screening for Gestational Diabetes Mellitus with Maternal Factors and Biomarkers Shen LX, Sahota DS, Chaemsaithong P, Tse WT, Chung MY, Ip JKH, Leung TY, Poon LCY Fetal Diagn Ther. 2022;49(5-6):256-264
17
Comparison of uterine artery Doppler measurements at 6 weeks of pregnancy after IVF between pregnancies that resulted in miscarriage and ongoing pregnancies. Guo J, Chaemsaithong P, Huang J, Chung JPW, Huang J, Poon LCY, Li TC. Int J Gynaecol Obstet. 2020 Sep 13.
18
(2020) Whole genome miRNA profiling revealed miR-199a as potential placental pathogenesis of selective fetal growth restriction in monochorionic twin pregnancies. Meng M, Cheng YKY, Wu L, Chaemsaithong P, Leung MBW, Chim SSC, Sahota DS, Li W, Poon LCY, Wang CC, Leung TY. Placenta 92:44-53.
19
Reproductive outcomes after surgical treatment of asherman syndrome: A systematic review. Guo EJ, Chung JPW, Poon LCY, Li TC. Best Pract Res Clin Obstet Gynaecol. 2019 Aug;59:98-114.
20
Prelabor short-term variability in fetal heart rate by computerized cardiotocogram and maternal fetal Doppler indices for the prediction of labor outcomes Lam MSN, Chaemsaithong P, Kwan AHW, Wong STK, Tse AWT, Sahota DS, Leung TY, Poon LC J Matern Fetal Neonatal Med. 2022 Apr;35(7):1318-1327
21
Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach Lees CC, Romero R, Stampalija T, Dall'Asta A, DeVore GA, Prefumo F, Frusca T, Visser GHA, Hobbins JC, Baschat AA, Bilardo CM, Galan HL, Campbell S, Maulik D, Figueras F, Lee W, Unterscheider J, Valensise H, Da Silva Costa F, Salomon LJ, Poon LC, Ferrazzi E, Mari G, Rizzo G, Kingdom JC, Kiserud T, Hecher K Am J Obstet Gynecol. 2022 Mar;226(3):366-378
22
Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcomes in pregnant women with COVID-19 Torres-Torres J, Espino-Y-Sosa S, Poon LC, Solis-Paredes JM, Estrada-Gutierrez G, Espejel-Nuñez A, Juarez-Reyes A, Etchegaray-Solana A, Alfonso-Guillen Y, Aguilar-Andrade L, Hernández-Pacheco JA, Villafan-Bernal JR, Martinez-Portilla RJ Ultrasound Obstet Gynecol. 2022 Feb;59(2):202-208
23
Prospective Evaluation of International Prediction of Pregnancy Complications Collaborative Network Models for Prediction of Preeclampsia: Role of Serum sFlt-1 at 11–13 Weeks’ Gestation Chaiyasit N, Sahota DS, Ma R, Choolani M, Wataganara T, Sim WS, Chaemsaithong P, Wah YMI, Hui ASY, Poon LC Hypertension. 2022 Feb;79(2):314-322
24
Comorbidity, poverty and social vulnerability as risk factors for mortality in pregnant women with confirmed SARS-CoV-2 infection: analysis of 13 062 positive pregnancies including 176 maternal deaths in Mexico Torres-Torres J, Martinez-Portilla RJ, Espino-Y-Sosa S, Estrada-Gutierrez G, Solis-Paredes JM, Villafan-Bernal JR, Medina-Jimenez V, Rodriguez-Morales AJ, Rojas-Zepeda L, Poon LC Ultrasound Obstet Gynecol. 2022 Jan;59(1):76-82
25
First trimester preeclampsia screening and prediction Chaemsaithong P, Sahota D, Poon LC Am J Obstet Gynecol. 2022 Feb;226(2S):S1071-S1097.e2.
26
Prevention of preeclampsia with aspirin Rolnik DL., Nicolaides KH, Poon LC Am J Obstet Gynecol. 2022 Feb;226(2S):S1108-S1119
27
The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, Kenny LC, McCarthy F, Myers J, Poon LC, Rana S, Saito S, Staff AC, Tsigas E, von Dadelszen P Pregnancy Hypertens. 2022 Mar;27:148-169
28
Bronchopulmonary sequestration successfully treated with prenatal radiofrequency ablation of the feeding artery Tse WT, Poon LC, Wah YMI, Hui ASY, Ting YH, Leung TY Ultrasound Obstet Gynecol. 2021 Aug;58(2):325-327
29
Impact of replacing or adding placental growth factor on Down syndrome screening: A prospective cohort study Sin AWT, Poon LC, Chaemsaithong P, Wah YMI, Hui ASY, Ting YH, Law KM, Leung TY, Sahota DS Prenat Diagn. 2021 Aug;41(9):1111-1117
30
Outcome of radiofrequency ablation for selective fetal reduction before vs at or after 16 gestational weeks in complicated monochorionic pregnancy Ting YH, Poon LCY, Tse WT, Chung MY, Wah YMI, Hui ASY, Law KM, Chaemsaithong P, Leung TY Ultrasound Obstet Gynecol. 2021 Aug;58(2):214-220
31
Update on diagnosis of hyperglycemia in pregnancy and gestational diabetes mellitus from FIGOƒs Pregnancy & Non- Communicable Diseases Committee Poon LC, Hod M, McIntyre HD, Oats JJN, Kihara AB, Divakar H, Kapur A Int J Gynaecol Obstet. 2021 Aug;154(2):189-194
32
A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics) Poon LC, Magee LA, Verlohren S, Shennan A, von Dadelszen P, Sheiner E, Hadar E, Visser G, Costa FD, Kapur A, McAuliffe F, Nazareth A, Tahlak M, Kihara AB, Divakar H, McIntyre HD, Berghella V, Yang HX, Romero R, Nicolaides KH, Melamed N, Hod M Int J Gynaecol Obstet. 2021 Jul;154 Suppl 1:3-31
33
Application of an individualized nomogram in first-trimester screening for trisomy 21 Sun Y, Zhang L, Dong D, Li X, Wang J, Yin C, Poon LC, Tian J, Wu Q Ultrasound Obstet Gynecol. 2021 Jul;58(1):56-66
34
Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent preterm preeclampsia in Belgium Dubon Garcia A, Devlieger R, Redekop K, Vandeweyer K, Verlohren S, Poon LC Pregnancy Hypertens. 2021 Jul 1;25:219-224
35
Prediction of spontaneous preterm birth by cervical length in the first trimester of pregnancy: comparison of two measurement methods Feng Q, Duan H, Ju X, Appiah K, Yip KM, Tai Y, Sun Q, Chaemsaithong P, Poon LC Acta Obstet Gynecol Scand. 2021 Jul;100(7):1305-1312
36
Accuracy of the FMF Bayes theorem-based model for predicting preeclampsia at 11-13 weeks of gestation in a Japanese population Goto M, Koide K, Tokunaka M, Takita H, Hamada S, Nakamura M, Matsuoka Ryu, Sekizawa A, Poon LC Hypertens Res. 2021 Jun;44(6):685-691
37
Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies Poon LC, Leung MBW, Ma T, Yu FN, Kong CW, Lo TK, So PL, Leung WC, Shu W, Cheung KW, Moungmaithong S, Wang CC Ultrasound Obstet Gynecol. 2021 Jun;57(6):974-978
38
Doppler-based predictive model for methotrexate resistancein low-risk gestational trophoblastic neoplasia withmyometrial invasion: prospective study of 147 patients Qin J, Zhang S, Poon L, Pan Z, Luo J, Yu N, Wang L, Wu X, Cheng X, Xie X, Lu Y, Lu W Ultrasound Obstet Gynecol. 2021 May;57(5):829-839
39
Equity in coronavirus disease 2019 vaccine development and deployment Modi N, Ayres-de-Campos D, Bancalari E, Benders M, Briana D, Di Renzo GC, Fonseca EB, Hod M, Poon L, Cortes MS, Simeoni U, Tscherning C, Vento M, Visser GHA, Voto L Am J Obstet Gynecol. 2021 May;224(5):423-427
40
First Trimester Screening for Preeclampsia: An Asian Perspective Moungmaithong S, Wang X, Tai AS, Feng Q, Sahota D, Leung TY, Poon LCY. Maternal-Fetal Medicine. 2021 Apr; 3(2):116-12
41
How Different Are Diverse Populations in Screening for Preeclampsia? Martinez-Portilla RJ, Poon LC Maternal-Fetal Medicine. 2021 Apr; 3(2):87-90
42
Preeclampsia: Universal Screening or Universal Prevention for Low and Middle-Income Settings? Rolnik DL, Carvalho MHB, Lobo GAR, Verlohren S, Poon L, Baschat A, Hyett J, Thilaganathan B, Bujold E, Costa FDS Rev Bras Ginecol Obstet. 2021 Apr;43(4):334-338
43
Young pregnant women are also at an increased risk of mortality and severe illness due to coronavirus disease 2019: Analysis of the Mexican National Surveillance Program Martinez Portilla RJ, Smith ER, He S, Torres JT, Espino-Y-Sosa S, Solis-Paredes JM, Poon LC Am J Obstet Gynecol. 2021 Apr;224(4):404-407
44
FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras F, Berghella V, Nazareth A, Tahlak M, McIntyre HD, Costa FD, Kihara AB, Hadar E, McAuliffe F, Hanson M, Ma RC, Gooden R, Sheiner E, Kapur A, Divakar H, Ayres-de-Campos D, Hiersch L, Poon LC, Kingdom J, Romero R, Hod M Int J Gynaecol Obstet. 2021 Mar;152 Suppl 1:3-57
45
Comparison of uterine artery Doppler measurements at 6 weeks of pregnancy after IVF between pregnancies that resulted in miscarriage and ongoing pregnancies Guo J, Chaemsaithong P, Huang J, Chung JPW, Huang J, Poon LCY, Li TC Int J Gynaecol Obstet. 2021 Feb;152(2):249-255
46
Genome-wide detection of cytosine methylation by single molecule real-time sequencing Tse OYO, Jiang P, Cheng SH, Peng W, Shang H, Wong J, Chan SL, Poon LCY, Leung TY, Chan KCA, Chiu RWK, Lo YMD Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):e2019768118
47
Scientific effort in combating COVID19 in obstetrics and gynecology Martinez-Portilla RJ, Gil MM, Poon LC Ultrasound Obstet Gynecol. 2021 Feb;57(2):189-194
48
Single-cell RNA expression profiling of SARS-CoV-2-related ACE2 and TMPRSS2 in human trophectoderm and placenta Cui D, Liu Y, Jiang X, Ding C, Poon LC, Wang H, Yang H Ultrasound Obstet Gynecol. 2021 Feb;57(2):248-256
49
Evidence of possible SARS-CoV-2 vertical transmission according to World Health Organization criteria in asymptomatic pregnant women Sevilla-Montoya R, Hidalgo-Bravo A, Estrada-GutiƒÂ©rrez G, Villavicencio-Carrisoza O, Gonzalez-GarcƒÂ­a LD, Leon-Juarez M, Mora-Vargas CD, Villegas-Mota I, Espino-y-Sosa S, Mateu-Rogell P, Rodriguez-Bosch M, Monroy-MuƒÂ±oz IE, Coronado-Zarco I, Acevedo-Gallegos S, Aguinaga-RƒÂ­os M, Ramirez-Santes VH, Ortiz-Ramirez MA, Valdes-Flores M, Cortes-Bonilla M, MartƒÂ­nez-Portilla R, Poon LC, Cardona-PƒÂ©rez JA, Helguera-Repetto AC Ultrasound Obstet Gynecol. 2021 Dec;58(6):900-908
50
Single-molecule sequencing reveals a large population of long cell-free DNA molecules in maternal plasma Yu SCY, Jiang P, Peng W, Cheng SH, Cheung YTT, Tse OYO, Shang H, Poon LC, Leung TY, Chan KCA, Chiu RWK, Lo YMD Proc Natl Acad Sci U S A. 2021 Dec 14;118(50):e2114937118
51
Effective aspirin treatment of women at risk for preeclampsia delays the metabolic clock of gestation Li X, Milosavljevic A, Elsea SH, Wang CC, Scaglia F, Syngelaki A, Nicolaides KH, Poon LC Hypertension. 2021 Nov;78(5):1398-1410
52
Perspectives on administration of COVID-19 vaccine to pregnant and lactating women: a challenge for low- and middle-income countries Duarte G, Coutinho CM, Rolnik DL, Quintana SM, Rabelo E Silva AC, Poon LC, Costa FDS AJOG Glob Rep. 2021 Nov;1(4):100020
53
ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis Shen L, Martinez-Portilla RJ, Rolnik DL, Poon LC Ultrasound Obstet Gynecol. 2021 Oct;58(4):546-552
54
Incidence of pre-eclampsia and other perinatal complications among pregnant women with congenital heart disease: systematic review and meta-analysis Martinez-Portilla RJ, Poon LC, Benitez-Quintanilla L, Sotiriadis A, Lopez M, Lip-Sosa DL, Figueras F Ultrasound Obstet Gynecol. 2021 Oct;58(4):519-528
55
Novel ratio soluble fms-like tyrosine kinase-1/Angiotensin-II (sFlt-1/ANG-II) in pregnant women is associated with critical illness in COVID-19 Espino-y-Sosa S, Martinez-Portilla RJ, Torres-Torres J, Mario Solis, Paredes J, Estrada-Gutierrez G, Hernandez-Pacheco AN, Espejel-NuƒÂƒ‚±ez A, Mateu-Rogell P, Juarez-Reyes A, Lopez-Ceh FE, Villafan-Bernal JR, Rojas-Zepeda L, Guzman-Guzman IP, Poon LC Viruses 2021 Oct; 13(10): 1906
56
Pregnancy and neonatal outcomes in COVID-19: study protocol for a global registry of women with suspected or confirmed SARS-CoV-2 infection in pregnancy and their neonates, understanding natural history to guide treatment and prevention Banerjee J, Mullins E, Townson J, Playle R, Shaw C, Kirby N, Munnery K, Bourne T, Teoh TG, Dhanjal M, Poon L, Wright A, Lees C BMJ Open. 2021 Jan 29;11(1):e041247
57
The significance of low first trimester serum progesterone in ongoing early pregnancies presenting as pregnancies of unknown location Ucyigit A, Fuller JL, Poon LC, J Johns, Ross JA Eur J Obstet Gynecol Reprod Biol. 2021 Jan 12;258:294-298
58
The Use of Somatex Shunt for Fetal Pleural Effusion: A Cohort of 8 Procedures Chung MY, Leung WC, Tse WT, Ting YH, Law KM, Hui ASY, Wah YMI, Lam HS, Poon LCY, Leung TY Fetal Diagn Ther. 2021;48(6):440-447
59
Whole genome miRNA profiling revealed miR199a as potential placental pathogenesis of selective fetal growth restriction in monochorionic twin pregnancies Meng M, Cheng YKK, Wu L, Chaemsaithong P, Leung MBW, Chim SSC, Sahota DS, Li W, Poon LCY, Wang CC, Leung TY Placenta Volume 92, Mar 2020, Pages 44-53
60
Detection and characterization of jagged ends of double-stranded DNA in plasma Jiang P, Xie T, Ding SC, Zhou Z, Cheng SH, Chan RWY, Lee WS, Peng W, Wong J, Wong VWS, Chan HLY, Chan SL, Poon LCY, Leung TY, Chan KCA, Chiu RWK, Lo YMD Genome Res. 2020 Aug;30(8):1144-1153
61
First-trimester pre-eclampsia biomarker profiles in Asian population: a multicenter cohort study Chaemsaithong P, Sahota DS, Pooh RK, Zheng M, Ma R, Chaiyasit N, Koide K, Shaw SW, Seshadri S, Choolani M, Panchalee T, Yapan P, Sim WS, Sekizawa A, Hu Y, Shiozaki A, Saito S, Leung TY, Poon LCÂ Â Ultrasound Obstet Gynecol. 2020 Aug;56(2):206-214
62
First-trimester pre-eclampsia biomarker profiles in Asian population: multicenter cohort study Chaemsaithong P, Sahota D, Pooh RK, Zheng M, Ma R, Chaiyasit N, Koide K, Shaw SW, Seshadri S, Choolani M, Panchalee T, Yapan P, Sim WS, Sekizawa A, Hu Y, Shiozaki A, Saito S, Leung TY, Poon LC Ultrasound Obstet Gynecol. 2020 Aug;56(2):206-214
63
ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction Lees CC, Stampalija T, Baschat A, da Silva Costa F, Ferrazzi E, Figueras F, Hecher K, Kingdom J, Poon LC, Salomon LJ, Unterscheider J Ultrasound Obstet Gynecol. 2020 Aug;56(2):298-312
64
Effect of race on longitudinal central hemodynamics in pregnancy Ling HZ, Garcia Jara P, Bisquera A, Poon LC, Nicolaides K, Kametas NA Ultrasound Obstet Gynecol. 2020 Jul;56(1):37-43
65
Effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes: a systematic review Juan J, Gil MM, Rong Z, Zhang Y, Yang H, Poon LC Ultrasound Obstet Gynecol. 2020 Jul;56(1):15-27
66
Maternal cardiac function in women at high risk for pre-eclampsia treated with 150 mg aspirin or placebo: an observational study Ling HZ, Jara PG, Bisquera A, Poon LC, Nicolaides KH, Kametas NA BJOG. 2020 Jul;127(8):1018-1025
67
Risk factors for anxiety and depression among pregnant women during the COVID-19 pandemic - a web-based cross-sectional survey Kajdy A, Feduniw S, Ajdacka U, Modzelewski J, Baranowska B, Sys D, Pokropek A, Pawlicka P, Kazmierczak M, Rabijewski M, Jasiak H, Lewandowska R, Borowski D, Kwiatkowski S, Poon LC Medicine (Baltimore). 2020 Jul 24;99(30):e21279
68
Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals Poon LC, Yang H, Kapur A, Melamed N, Dao B, Divakar H, David McIntyre H, Kihara AB, Ayres-de-Campos D, Ferrazzi EM, Carlo Di Renzo G, Hod M Int J Gynaecol Obstet. 2020 Jun;149(3):273-286
69
Intrauterine vertical transmission of SARS-CoV-2: what we know so far Wang C, Zhou YH, Yang HX, Poon LC Ultrasound Obstet Gynecol. 2020 Jun;55(6):724-725
70
Intrauterine vertical transmission of SARS-CoV-2: what we know so far (opinion) Wang C, Zhou YH, Yang HX, Poon LCƒ ƒ ƒ ƒ ƒ Ultrasound Obstet Gynecol. 2020 Jun;55(6):724-725
71
ISUOG Consensus Statement on organization of routine and specialist obstetric ultrasound services in context of COVID-19 Abu-Rustum RS, Akolekar R, Sotiriadis A, Salomon LJ, Da Silva Costa F, Wu Q, Frusca T, Bilardo CM, Prefumo F, Poon LC Ultrasound Obstet Gynecol. 2020 Jun;55(6):863-870
72
ISUOG Consensus Statement on organization of routine and specialist obstetric ultrasound services in context of COVID-19. (opinion) Abu-Rustum RS, Akolekar R, Sotiriadis A, Salomon LJ, Da Silva Costa F, Wu Q, Frusca T, Bilardo CM, Prefumo F, Poon LC Ultrasound Obstet Gynecol. 2020 Jun;55(6):863-870
73
ISUOG Interim Guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium: information for healthcare professionals - an update Poon LC, Yang H, Dumont S, Lee JCS, Copel JA, Danneels L, Wright A, Costa FD, Leung TY, Zhang Y, Chen D, Prefumo F Ultrasound Obstet Gynecol. 2020 Jun;55(6):848-862
74
ISUOG Interim Guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium: information for healthcare professionals - an update (INTERIM GUIDANCE) Poon LC, Yang H, Dumont S, Lee JCS, Copel JA, Danneels L, Wright A, Costa FD, Leung TY, Zhang Y, Chen D, Prefumo F Ultrasound Obstet Gynecol. 2020 Jun;55(6):848-862
75
ISUOG Safety Committee Position Statement on use of personal protective equipment and hazard mitigation in relation to SARS-CoV-2 for practitioners undertaking obstetric and gynecological ultrasound Abramowicz JS, Basseal JM, Brezinka C, Dall'Asta A, Deng J, Harrison G, Lee JCS, Lim A, Maršal K, Miloro P, Poon LC, Salvesen KÅ, Sande R, Ter Haar G, Westerway SC, Xie MX, Lees C Ultrasound Obstet Gynecol. 2020 Jun;55(6):886-891
76
Placental microRNA dataset of monochorionic twin pregnancies with and without selective fetal growth restriction Meng M, Cheng YKK, Wu L, Chaemsaithong P, Leung MBW, Chim SSC, Sahota DS, Li W, Poon LCY, Wang CC, Leung TY Data in Brief , Volume 30, Jun 2020, 105403, 5 pages
77
Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic Kwiatkowski S, Borowski D, Kajdy A, Poon LC, Rokita W, Wielgos M Ultrasound Obstet Gynecol. 2020 Jun;55(6):841-843
78
Why we should not stop giving aspirin to pregnantwomen during the COVID-19 pandemic (Letters to editor) Kwiatkowski S, Borowski D, Kajdy A, Poon LC, Rokita W, Wielgos Mƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ Ultrasound Obstet Gynecol. 2020 Jun;55(6):841-843
79
Does low-dose aspirin initiated before 11 weeks’ gestation reduce the rate of preeclampsia? Chaemsaithong P, Cuenca-Gomez D, Plana MN, Gil MM, Poon LC Am J Obstet Gynecol. 2020 May;222(5):437-450
80
ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals Poon LC, Yang H, Lee JCS, Copel JA, Leung TY, Zhang Y, Chen D, Prefumo F Ultrasound Obstet Gynecol. 2020 May;55(5):700-708
81
ISUOG Safety Committee Position Statement: safe performance of obstetric and gynecological scans and equipment cleaning in the context of COVID-19 Poon LC, Abramowicz JS, Dall'Asta A, Sande R, Ter Haar G, Maršal K, Brezinka C, Miloro P, Basseal J, Westerway SC, Abu-Rustum RS, Lees C Ultrasound Obstet Gynecol. 2020 May,55(5):709-712
82
Plasma DNA end motif profiling as a fragmentomic marker in cancer, pregnancy and Transplantation Jiang P, Sun K, Peng W, Cheng SH, Ni M, Yeung PC, Heung MMS, Xie T, Shang H, Zhou Z, Chan RWY, Wong J, Wong VWS, Poon LC, Leung TY, Lam WKJ, Chan JYK, Chan HLY, Chan KCA, Chiu RWK, Lo YMD Cancer Discov. 2020 May;10(5):664-673
83
Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases Yan J, Guo J, Fan C, Juan J, Yu X, Li J, Feng L, Li C, Chen H, Qiao Y, Lei D, Wang C, Xiong G, Xiao F, He W, Pang Q, Hu X, Wang S, Chen D, Zhang Y, Poon LC, Yang H Am J Obstet Gynecol. 2020 Apr 23;223(1):111.e1-111.e14
84
Novel coronavirus infection and pregnancy Yang H, Wang C, Poon LC Ultrasound Obstet Gynecol. 2020 Apr;55(4):435-437
85
Whole genome miRNA profiling revealed miR-199a as potential placental pathogenesis of selective fetal growth restriction in monochorionic twin pregnancies Meng M, Cheng YKK, Wu L, Chaemsaithong P, Leung MBW, Chim SSC, Sahota DS, Li W, Poon LCY, Wang CC, Leung TY Placenta Volume 92, March 2020, Pages 44-53
86
Monochorionic twins with selective fetal growth restriction: insight from placental whole-transcriptome analysis LI W, Chung CYL, Wang CC, Chan TF, Leung MBW, Chan OK, Wu L, APPIAH K, Chaemsaithong P, Cheng YKY, Poon LCY, Leung TY Am J Obstet Gynecol. 2020 Nov;223(5):749.e1-749.e16
87
Shear-wave sonoelastographic assessment of cervix in pregnancy Duan H, Chaemsaithong P, Ju X, Ho SYS, Sun Q, Tai Y, Leung TY, Poon LC Acta Obstet Gynecol Scand. 2020 Nov;99(11):1458-1468
88
Does Low-Dose Aspirin Initiated Before 11 Weeks' Gestation Reduce the Rate of Preeclampsia? (COMMENT) Chaemsaithong P, Cuenca-Gomez D, Plana MN, Gil MM, Poon LC Obstetrical & Gynecological Survey. 2020 Oct ;75(10):581-582
89
Feasibility, Reliability and Agreement of Transperineal Ultrasound Measurement: Results from a Longitudinal Cohort Study Kwan AHW, Chaemsaithong P, Tse WT, Appiah K, Chong KC, Leung TY, Poon LC Fetal Diagn Ther 2020 Oct;47(10):721-730
90
From first trimester screening to risk stratification of evolving preeclampsia in the second and third trimester of pregnancy - A comprehensive approach Poon LC, Galindo A, Surbek D, Chantraine F, Stepan H, Hyett J, Tan KH, Verlohren S Ultrasound Obstet Gynecol. 2020 Jan;55(1):5-12
91
The predictive value of cervical shear wave elastography in the outcome of labor induction Lu J, Cheng YKY, Ho SYS, Sahota DS, Hui LL, Poon LC, Leung TY Acta Obstet Gynecol Scand. 2020 Jan;99(1):59-68
92
Risk factors for anxiety and depression among pregnant women during the COVID-19 pandemic A web-based cross-sectional survey Kajdy A, Feduniw S, Ajdacka U, Modzelewski J, Baranowska B, Sys D, Pokropek A, Pawlicka P, Kazmierczak M, Rabijewski M, Jasiak H, Lewandowska R, Borowski D, Kwiatkowski S, Poon LCƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ Medicine (Baltimore). 2020 Jul 24;99(30):e21279ƒ ƒ ƒ ƒ ƒ ƒ ƒ ƒ
93
The effect of race on longitudinal maternal central hemodynamics Ling HZ, Garcia Jara P, Bisquera A, Poon LC, Nicolaides K, Kametas NA Ultrasound Obstet Gynecol. 2020 Jul;56(1):37-43ƒ ƒ ƒ ƒ ƒ
94
Erratum to "The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention" Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, da Silva Costa F, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D'Alton M, Berghella V, Nicolaides KH, Hod M Int J Gynaecol Obstet. 2019 Sep;146(3):390-391
95
FIGO (International Federation of Gynecology and Obstetrics) Postpregnancy Initiative: Long-term maternal implications of pregnancy complications-follow-up considerations. Sheiner E, Kapur A, Retnakaran R, Hadar E, Poon LC, Mclntyre HD, Divakar H, Staff AC, Narula J, Kihara AB, Hod M. Int J Gynaecol Obstet 2019 Sep;147:1-31
96
Increased Sylvian fissure angle as early sonographic sign of malformation of cortical development Pooh RK, Machida M, Nakamura T, Uenishi K, Chiyo H, Itoh K, Yoshimatsu J, Ueda H, Ogo K, Chaemsaithong P, Poon LC Ultrasound Obstet Gynecol. 2019 Aug;54(2):199-206
97
Reproductive outcomes after surgical treatment of asherman syndrome: A systematic review Guo EJ, Chung JPW, Poon LC, Li TC Best Pract Res Clin Obstet Gynaecol. 2019 Aug;59:98-114
98
Transvaginal three-dimensional assessment of Sylvian fissures at 18-30 weeks’ gestation Poon LC, Sahota DS, Chaemsaithong P, Nakamura T, Machida M, Naruse K, Wah YMI, Leung TY, Pooh RK Ultrasound Obstet Gynecol. 2019 Aug;54(2):190-198
99
Inter-manufacturer comparison of automated immunoassays for the measurement of soluble FMS-like tyrosine kinase-1 and placental growth factor Cheng YKY, Poon LC, Shennan A, Leung TY, Sahota DS Pregnancy Hypertens. 2019 Jul;17:165-171
100
Maternal hemodynamics in screen-positive and screen-negative women of the ASPRE trial Ling HZ, Guy GP, Bisquera A, Poon LC, Nicolaides KH, Kametas NA Ultrasound Obstet Gynecol. 2019 Jul;54(1):51-57
101
Body mass index at 11-13 weeks’ gestation and pregnancy complications in a Southern Chinese population: a retrospective cohort study Chaemsaithong P, Leung TY, Sahota D, Cheng YKY, Leung WC, Lo TK, Poon LCY J Matern Fetal Neonatal Med. 2019 Jun;32(12):2056-2068
102
Do specific ultrasonography features identified at the time of early pregnancy loss predict fetal chromosomal abnormality? A systematic review and meta-analysis Huang J, Zhu W, Tang J, Saravelos SH, Poon LC, Li TC Genes Dis. 2019 Jun 6(2):129-137
103
Factors that affect ultrasound-determined labor progress in women undergoing induction of labor Chaemsaithong P, Kwan AHW, Tse WT, Lim WT, Chan WYW, Chong KC, Leung TY, Poon LC Am J Obstet Gynecol. 2019 Jun;220(6):592.e1-592.e15
104
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, Costa FD, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D'Alton M, Berghella V, Nicolaides KH, Hod M, Hod M Int J Gynaecol Obstet. 2019 May;145 Suppl 1:1-33
105
Impact of preimplantation genetic testing for aneuploidy on obstetrical practice Chan OYM, Li TC, Poon LC Curr Opin Obstet Gynecol. 2019 Apr;31(2):127-131
106
Pre-induction transperineal ultrasound assessment for the prediction of labor outcome Chan WWY, Chaemsaithong P, Lim WT, Tse WT, Kwan AHW, Leung TY, Sahota DS, Poon LC Fetal Diagn Ther. 2019 Apr;45(4):256-267
107
Good clinical practice advice: First trimester screening and prevention of pre- eclampsia in singleton pregnancy FIGO Working Group on Good Clinical Practice in MaternaFetal Medicine Poon LC Int J Gynaecol Obstet. 2019 Mar;144(3):325-329
108
Prenatal visualization of paraumbilical veins in fetus with intra-abdominal umbilical vein stricture and intrauterine growth restriction Chan YM, Law KM, Poon LC, Leung TY Ultrasound Obstet Gynecol. 2019 Nov;54(5):697-698
109
Reasons for accepting or declining participation in the ASPRE trial: A qualitative study with women at high-risk of preterm-PE NikƒÂ„‚eviƒÂ„‚‡ AV, Dodd Z, Prior J, OƒÂ¢‚€‚™Gorman N, Poon LC, Nicolaides KH Prenat Diagn. 2019 Nov;39(12):1127-1135
110
Objective assessment of the fetal facial profile at second and third trimester of pregnancy Lu J, Sahota DS, Poon LCY, Ting YH, Cheng YKY, Wang Y, Leung TY Prenat Diagn. 2019 Jan;39(2):107-115
111
Clinical evaluation of a first trimester pregnancy algorithm predicting the risk of small for gestational age neonates Graham K, Park F, McLennan A, Pelosi M, Williams P, Poon LC, Hyett J Aust N Z J Obstet Gynaecol. 2019 Oct;59(5):670-676
112
Omics and perinatal medicine Preeclampsia Chaemsaithong P, Poon LC In: New Technologies and Perinatal Medicine: Prediction and Prevention of Pregnancy Complications
113
Prediction of labor outcome using serial transperineal ultrasound in the first stage of labor Chor CM, Poon LC, Leung TY J Matern Fetal Neonatal Med. 2019 Jan;32(1):31-37
114
Prevention of Spontaneous Preterm Birth Appiah K, Chaemsaithong P, Poon LC MIMS JPOG 2019 ; 45 (4); 169-176
115
Screening and prevention of pre-eclampsia: a review Chaemsaithong P, Appiah K, Sahota DS , Leung TY, Poon LC Hong Kong J Gynaecol Obstet Midwifery 2019;19(1):56-72
116
Uterine artery pulsatility index in the first trimester: assessment of intersonographer and intersampling site measurement differences Chaemsaithong P, Ting YH, Cheng KYY, Poon LC, Leung TY, Sahota DS J Matern Fetal Neonatal Med. 2018 Sep;31(17):2276-2283
117
Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE Tan MY, Poon LC, Rolnik DL, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Greco E, Papaioannou G, Wright D, Nicolaides KH Ultrasound Obstet Gynecol. 2018 Jul;52(1):52-59
118
ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm Poon LC, Rolnik DL, Tan MY, Delgado JL, Tsokaki T, Akolekar R, Singh M, Andrade W, Efeturk T, Jani JC, Plasencia W, Papaioannou G, Blazquez AR, Carbone IF, Wright D, Nicolaides KH Ultrasound Obstet Gynecol. 2018 Jun;51(6):738-742
119
Effect of change in posture on maternal functional hemodynamics at 35“37 weeks™ gestation Guy GP, Ling HZ, Machuca M, Poon LC, Nicolaides KH Ultrasound Obstet Gynecol. 2018 Mar;51(3):368-374
120
Updates on Screening, Prevention, Treatment, and Genetic Markers for Preeclampsia Palomaki GE, Martin JN Jr, Karumanchi SA, Poon LC Clin Chem. 2018 Dec;64(12):1684-1689
121
The first-trimester of pregnancy - a window of opportunity for prediction and prevention of pregnancy complications and future lifeƒ ƒ Poon LC, McIntyre HD, Hyett JA, da Fonseca EB, Hod M Diabetes Res Clin Pract. 2018 Nov;145:20-30
122
Transverse technique: complementary approach to measurement of first-trimester uterine artery Doppler Drouin O, Johnson J, Metcalfe A, Huber J, Schwarzenberger J, Winters E, Stavness L, Chaemsaithong P, Tse AWT, Lu J, Lim WT, Leung TY, Bujold E, Sahota DS, Poon LC Ultrasound Obstet Gynecol. 2018 Nov;52(5):639-647
123
Maternal hemodynamics, fetal biometry and Doppler indices in pregnancies followed up for suspected fetal growth restriction Roberts LA, Ling HZ, Poon LC, Nicolaides KH, Kametas NA Ultrasound Obstet Gynecol. 2018 Oct;52(4):507-514
124
Comment on "First Trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors" Sahota DS, Poon LCY Prenat Diagn. 2018 Oct;38(11):891, 1 page
125
Protocol for the prospective validation study: 'Screening programme for pre-eclampsia' (SPREE) Tan MY, Koutoulas L, Wright D, Nicolaides KH, Poon LC Ultrasound Obstet Gynecol. 2017 Aug;50(2):175-179
126
Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11“13 weeks' gestation O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, Akolekar R, Cicero S, Janga D, Jani J, Molina F S, Paco Matallana C, Papantoniou N, Persico N, Plasencia W, Singh M, Nicolaides K H Ultrasound Obstet Gynecol 2017 Jun;49(6):751-755
127
Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks: a randomized controlled study . E. Scazzocchio, D. Oros, D. Diaz, J. C. Ramirez, M. Ricart, E. Meler, R. Gon¡lez de Agero, E. Gratacos and F. Figueras Poon LC Ultrasound Obstet Gynecol. 2017 Apr;49(4):433
128
Integrated Proteomic and Metabolomic prediction of Term Preeclampsia Bahado-Singh R, Poon LC, Yilmaz A, Syngelaki A, Turkoglu O, Kumar P, Kirma J, Allos M, Accurti V, Li J, Zhao P, Graham SF, Cool DR, Nicolaides K Sci Rep. 2017 Nov 23;7(1):16189 (Page 1-10)
129
ASPRE trial: performance of screening for preterm pre-eclampsia Rolnik DL, Wright D, Poon LC, Syngelaki A, O'Gorman N, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Nicolaides KH Ultrasound Obstet Gynecol 2017 Oct;50(4):492-495
130
Protocol for measurement of mean arterial pressure at 10-40 weeks’ gestation Roberts L, Chaemsaithong P, Sahota DS, Nicolaides KH, Poon LCY Pregnancy Hypertens. 2017 Oct;10:155-160
131
Maternal cardiac function at 35-37 weeks' gestation: prediction of preeclampsia and gestational hypertension Guy GP, Ling HZ, Garcia P, Poon LC, Nicolaides KH Ultrasound in Obstetrics and Gynecology Jan 2017;49(1):61-66
132
Maternal cardiac function at 35-37 weeks' gestation: relationship with birth weight Guy G.P., Ling H.Z., Machuca M., Poon LC, Nicolaides K.H. Ultrasound Obstet Gynecol. 2017 Jan;49(1):67-72
133
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history Poon LC, Wright D, Rolnik DL, Syngelaki A, Delgado JL, Tsokaki T, Leipold G, Akolekar R, Shearing S, De Stefani L, Jani JC, Plasencia W, Evangelinakis N, Gonzalez-Vanegas O, Persico N, Nicolaides KH Am J Obstet Gynecol. 2017 Nov;217(5):585.e1-585.e5
134
Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia Wright D, Poon LC, Rolnik DL, Syngelaki A, Delgado JL, Vojtassakova D, de Alvarado M, Kapeti E, Rehal A, Pazos A, Carbone IF, Dutemeyer V, Plasencia W, Papantoniou N, Nicolaides KH Am J Obstet Gynecol. 2017 Dec;217(6):685.e1-685.e5
135
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH N Engl J Med. 2017 Aug 17;377(7):613-622
136
Maternal Cardiovascular Function at 35-37 Weeks' Gestation: Relation to Maternal Characteristics Guy GP, Ling HZ, Garcia P, Poon LC, Nicolaides KH Ultrasound in Obstetrics and Gynecology Jan 2017;49(1):39-45
137
Metabolomic determination of pathogenesis of late-onset preeclampsia Bahado-Singh RO, Syngelaki A, Mandal R, Graham SF, Akolekar R, Han B, Bjondahl TC, Dong E, Bauer S, Alpay-Savasan Z, Turkoglu O, Ogunyemi D, Poon LC, Wishart DS, Nicolaides KH J Matern Fetal Neonatal Med. 2017 Mar;30(6):658-664
138
Birth weight in live births and stillbirths Poon LC, Tan MY, Yerlikaya G, Syngelaki A, Nicolaides KH Ultrasound Obstet Gynecol Nov 2016;48(5):602-606
139
Cervical Cerclage for Preterm Birth Prevention in Twin Gestations with Short Cervix: A Case-Control_ Study. Houlihan C, Poon LC, Ciarlo M, Kim E, Guzman ER, Nicolaides KH. Ultrasound Obstet Gynecol 2016, doi: 10.1002/uog.15918.
140
Cervical pessaries for prevention of preterm birth: a randomised controlled trial. Nicolaides KH, Syngelaki A, Poon LC, De Paco C, Plasencia W, Molina F, Picciarelli G, Tul N, Celik E, Lau TK, Conturso R. Am J Obstet Gynecol 2016, 214:3.e1-9
141
Cervical pessary for prevention of preterm birth in singleton pregnancies with short cervical length: a multicentre, randomized controlled trial. Nicolaides KH, Syngelaki A, Poon LC, Picciarelli G, Tul N, Zamprakou A, Skyfta E, Parra-Cordero M, Palma-Dias R, Rodriquez Calvo J. New England Journal of Medicine 2016; 374:1044-52.
142
Clinical implementation of routine screening for fetal trisomies by the cell-free DNA test contingent on results from first-trimester combined test. Gil MM, Revello R, Poon LC, Akolekar R, Nicolaides KH. Ultrasound Obstet Gynecol 2016; 47:45-52.
143
Clinical validation of the ION test for first-trimester detection of trisomy 21, 18 and 13. Poon LC, Dumidrascu-Diris D, Francisco C, Fantasia I, Nicolaides KH. Ultrasound Obstet Gynecol 2016; 47:184-187
144
Contingent Screening for Small by Weight for Gestational Age Neonates. Frick AP,ƒ Nicolaidesƒ KH,ƒ Poonƒ LC. Pediatr Endocrinol Rev 2016;13:568-573.
145
First trimester prediction of HELLP Syndrome. Oliveira N, Poon LC, Nicolaides KH, Baschat AA. Prenatal diagnosis 2016; 36:29-33.
146
Metabolomic Determination of Pathogenesis of Late-onset Preeclampsia. Bahado-Singh RO, Syngelaki A, Mandal R, Akolekar R, Han B, Bjondahl TC, Dong E, Bauer S, Alpay-Savasan Z, Graham S, Turkoglu O, Ogunyemi D, Poon LC, Wishart DS, Nicolaides KH. Journal of Maternal Fetal and Neonatal Medicine 2016, J Matern Fetal Neonatal Med. 2016; 28: 1-7.
147
Prediction of large for gestational age neonates: Screening by maternal factors and biomarkers in the three trimesters of pregnancy. Frick A, Syngelaki S, Zheng MM, Poon LC*, Nicolaides KH. Ultrasound in Obstet Gynecol 2016;47:332-339.
148
Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE). O'Gorman N, Wright D, Rolnik DL, Nicolaides KH, Poon LC BMJ Open. 2016 Jun 28;6(6):e011801. doi: 10.1136/bmjopen-2016-011801.
149
The prediction of preterm birth in twin pregnancy: an individual patient level meta-analysis. Kindinger LM, Poon LC, Cacciatore S, MacIntyre, Fox NS, Schuit E, Mol B, Liem S, Lim A, Hermans F, Serra V, Perales A, Darzi A, Bennett P, Nicolaides KH, Teoh TG. British J Obstet Gynaecol 2016; 123:877-884.
150
The use of ultrasound and other markers for early detection of preeclampsia. OGorman N, Nicolaides KH,ƒ Poon LC. Womens Health (Lond Engl) 2016;12:199-207.
151
Current controversies in prenatal diagnosis 3: Is there still a Value in a Nuchal Translucency Screening Ultrasound in conjunction with Maternal Plasma Non-Invasive cell free DNA testing Wilson RD, Poon LC, and Ghidini A. Prenatal Diagnosis 2015; doi: 10.1002/pd.4719. [Epub ahead of print_]
152
Demographic factors that can be used to predict early-onset pre-eclampsia. Leung C, Saaid R, Pedersen L, Park F, Poon L, Hyett J. J Matern Fetal Neonatal Med 2015; 28: 535-539.
153
Fetal fraction in maternal plasma cell-free DNA in the prediction of spontaneous preterm delivery. Quezada MS, Francisco C, Dumitrascu-Biris D, Nicolaides KH, Poon LC*. Ultrasound Obstet Gynecol 2015; 45: 101-105.
154
Maternal plasma cell-free DNA in the prediction of preeclampsia. Rolnik DL, OƒÂ¢‚€‚™Gorman N, Fiolna M, van den Boom D, Nicolaides KH, Poon LC*. Ultrasound Obstet Gynecol 2015; 45: 106-111.
155
Maternal serum anti-Mllerian hormone at 11-13 weeks' gestation in the prediction of preeclampsia. Birdir C, Fryze J, Vasiliadis H, Nicolaides KH,ƒ Poon LC*. J Matern Fetal Neonatal Med 2015; 28: 954-958.
156
Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Wright A, Wright D, Ispas CA,ƒ Poonƒ LC,ƒ Nicolaidesƒ KH. Ultrasound Obstet Gynecol 2015; 45: 698-706.
157
Poon L. Re: Prediction of early- and late-onset pregnancy-induced hypertension using placental volume on three-dimensional ultrasound and uterine artery Doppler. T. Arakaki, J. Hasegawa, M. Nakamura, S. Hamada, M. Muramoto, H. Takita, K. Ichizuka and A. Sekizawa. Ultrasound Obstet Gynecol 2015; 45: 539-543. Ultrasound Obstet Gynecol 2015;45:513.
158
Prediction of small for gestational age neonates: screening by biophysical and biochemical markers at 19-24 weeks. Poonƒ LC, Lesmes C, Gallo DM, Akolekar R,ƒ Nicolaidesƒ KH. Ultrasound Obstet Gynecol. 2015 May 18. doi: 10.1002/uog.14904. [Epub ahead of print_]
159
Prediction of small for gestational age neonates: screening by fetal biometry at 19-24 weeks. Lesmes C, Gallo D, Panaiotova J,ƒ Poonƒ LC*,ƒ Nicolaidesƒ KH. Ultrasound Obstet Gynecol 2015; 46: 198-207.
160
Prediction of small for gestational age neonates: screening by fetal biometry at 30-34 weeks. Bakalis S, Silva M, Akolekar R,ƒ Poonƒ LC*,ƒ Nicolaidesƒ KH. Ultrasound Obstet Gynecol 2015; 45: 551-558.
161
Prediction of small for gestational age neonates: Screening by maternal serum biochemical markers at 19-24 weeks. Lesmes C, Gallo DM, Gonzalez R,ƒ Poonƒ LC*,ƒ Nicolaidesƒ KH. Ultrasound Obstet Gynecol. 2015 May 13. doi: 10.1002/uog.14899. [Epub ahead of print_]
162
Prediction of small for gestational age neonates: screening by uterine artery Doppler and mean arterial pressure at 19-24 weeks. Lesmes C, Gallo DM, Saiid Y,ƒ Poonƒ LC*,ƒ Nicolaidesƒ KH. Ultrasound Obstet Gynecol. 2015 Mar 24. doi: 10.1002/uog.14855. [Epub ahead of print_]
163
Prediction of small for gestational age neonates: Screening by uterine artery Doppler and mean arterial pressure at 30-34 weeks. Bakalis S, Stoilov B, Akolekar R,ƒ Poonƒ LC*,ƒ Nicolaidesƒ KH. Ultrasound Obstet Gynecol 2015; 45: 707-714.
164
Prediction of small-for-gestational-age neonates: maternal biochemical markers at 30-34 weeks. Bakalis S, Gallo DM, Mendez O,ƒ Poonƒ LC*,ƒ Nicolaidesƒ KH. Ultrasound Obstet Gynecol 2015; 46: 208-215.
165
Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks. Bakalis S, Peeva G, Gonzalez R,ƒ Poonƒ LC*,ƒ Nicolaidesƒ KH. Ultrasound Obstet Gynecol. 2015 Mar 31. doi: 10.1002/uog.14863. [Epub ahead of print_]
166
Prediction of small-for-gestational-age neonates: screening by fetal biometry at 35-37 weeks. Fadigas C, Saiid Y, Gonzalez R,ƒ Poonƒ LC*,ƒ Nicolaidesƒ KH. Ultrasound Obstet Gynecol 2015; 45: 559-565.
167
Prediction of small-for-gestational-age neonates: screening by placental growth factor and soluble fms-like tyrosine kinase-1 at 35-37 weeks. Fadigas C, Peeva G, Mendez O,ƒ Poonƒ LC*,ƒ Nicolaidesƒ KH. Ultrasound Obstet Gynecol 2015; 46: 191-197.
168
Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 35-37 weeks. Fadigas C, Guerra L, Garcia-Tizon Larroca S,ƒ Poonƒ LC*,ƒ Nicolaidesƒ KH. Ultrasound Obstet Gynecol 2015; 45: 715-721.
169
Risk of preterm birth following treatment for cervical disease: Stakeholder meeting summary. Sasieni P, Castanon A, Landy R, Kyrgiou M, Kitchener H, Quigley M, Poon LC, Shennan A, Paraskevaidis E, Hollingworth A, Soutter P, Freeman Wang T, Peebles D, Prendeville W, Patnick J. British J Obstet Gynaecol 2015; doi: 10.1111/1471-0528.13839.
170
UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: Factors affecting uptake. Gil MM, Giunta G, Macalli EA, Poon LC, Nicolaides KH. Ultrasound Obstet Gynecol 2015; 45: 67-73.
171
Umbilical and fetal middle cerebral artery Doppler at 30-34 weeks' gestation in the prediction of adverse perinatal outcome. Bakalis S, Akolekar R, Gallo DM,ƒ Poonƒ LC*,ƒ Nicolaidesƒ KH. Ultrasound Obstet Gynecol 2015; 45: 409-420.
172
Umbilical and fetal middle cerebral artery Doppler at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. Akolekar R, Syngelaki A, Gallo DM,ƒ Poonƒ LC,ƒ Nicolaidesƒ KH. Ultrasound Obstet Gynecol 2015; 46: 82-92.
173
Competing risk model in screening for preeclampsia by mean arterial pressure and uterine artery pulsatility index at 30-33 weeks' gestation. Tayyar A, Garcia-Tizon Larroca S,ƒ Poon LC, Wright D, Nicolaides KH. Fetal Diagn Ther. 2014; 36: 18-27.
174
Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks™ gestation. Lai J, Garcia-Tizon Larroca S, Peeva G, Poon LC, Wright D, Nicolaides KH. Fetal Diagn Ther 2014; 35: 240-248.
175
Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks_x0099_ gestation. Lai J, Garcia-Tizon Larroca S, Peeva G, Poon LC, Wright D, Nicolaides KH. Fetal Diagn Ther 2014; 35: 240-248.
176
Early prediction of preeclampsia. Poon LC, Nicolaides KH. Obstet Gynecol Int. 2014; 2014: 297397.
177
First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing. Nicolaides KH, Syngelaki A, Poon LC, Gil M, Wright D. Fetal Diagn Ther 2014; 35: 185-192.
178
First-trimester maternal factors and biomarker screening for preeclampsia. Poon LC, Nicolaides KH. Prenat Diagn 2014; 34: 618-627.
179
How feasible is expectant management of interstitial ectopic pregnancy? Poon LC, Emmanuel E, Ross J, Johns J. Ultrasound Obstet Gynecol 2013, Ultrasound Obstet Gynecol 2014; 43: 317-321.
180
Is High Fetal Nuchal Translucency Associated with Submicroscopic Chromosomal Abnormalities by Array CGH? Huang J, Poon LC, Akolekar R, Choy KW, Leung TY, Nicolaides KH. Ultrasound Obstet Gynecol 2014; 43: 620-624.
181
Management of hypertriglyceridaemia-induced acute pancreatitis in pregnancy. Aminƒ T,ƒ Poonƒ L, Teoh T, Moorthy K, Robinson S. J Matern Fetal Neonatal Med. 2014 Jul 29:1-13. [Epub ahead of print_]
182
Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11-13, 20-24 and 30-34 weeks gestation in late onset preeclampsia and small for gestational age. Nucci M, Poon LC, Demirdjian G, Darbouret B, Nicolaides KH. Fetal Diagn Ther 2014; 35: 249-257.
183
Optimal method and timing of intrauterine intervention in TRAP sequence: case study and meta-analysis. Chaveeva P, Poon LC, Sotiriadis A, Kosinski P, Nicolaides KH. Fetal Diagn Ther 2014; 35: 267-279.
184
Prediction of preeclampsia by mean arterial pressure at 11-13 and 20-24 weeks™ gestation. Gallo D, Poon LC, Fernandez M, Wright D, Nicolaides KH. Fetal Diagn Ther 2014; 36: 28-37.
185
Prediction of preeclampsia by mean arterial pressure at 11-13 and 20-24 weeks_x0099_ gestation. Gallo D, Poon LC, Fernandez M, Wright D, Nicolaides KH. Fetal Diagn Ther 2014; 36: 28-37.
186
Successful induction of labor: prediction by pre-induction cervical length, angle of progression and cervical elastography. Pereira S, Frick AP, Poon LC, Zamprakou A, Nicolaides KH. Ultrasound Obstet Gynecol 2014; 44: 468-475.
187
Association of placental perfusion, as assessed by magnetic resonance imaging and uterine artery Doppler ultrasound, and its relationship to pregnancy outcome. Derwig I, Lythgoe DJ, Barker GJ, Poon L, Gowland P, Yeung R, Fernando Z, Nicolaides, KH. Placenta 2013; 34: 885-891.
188
Association of placental T2 relaxation times and uterine artery Doppler ultrasound measures of placental blood flow. Derwig I, Barker GJ, Poon L, Zelaya F, Gowland P, Lythgoe DJ, Nicolaides KH. Placenta 2013; 34: 474-479.
189
Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. Park FJ,ƒ Leung CH,ƒ Poonƒ LC,ƒ Williams PF,ƒ Rothwell SJ,ƒ Hyettƒ JA. Aust N Z J Obstet Gynaecolƒ 2013; 53: 532-539.
190
Combined screening for preeclampsia and small for gestational age at 11_x0093_13 weeks. Poon LC, Syngelaki A, Akolekar R, Lai J, Nicolaides KH. Fetal Diagn Ther 2013; 33: 16-27.
191
Combined screening for preeclampsia and small for gestational age at 11“13 weeks. Poon LC, Syngelaki A, Akolekar R, Lai J, Nicolaides KH. Fetal Diagn Ther 2013; 33: 16-27.
192
Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Akolekar R, Syngelaki A, Poon LC, Wright D, Nicolaides KH. Fetal Diagn Ther 2013; 33: 8-15.
193
Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ashoor G, Syngelaki A,ƒ Poonƒ L, Rezende J,ƒ Nicolaidesƒ K. , Poon LC Ultrasound Obstet Gynecol 2013; 41: 26-32.
194
First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell free DNA testing. Nicolaides KH, Wright D, Poon L,ƒ Syngelaki A, Gil M. Ultrasound Obstet Gynecol 2013; 42: 41-50.
195
Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks gestation: Relation to fetal and maternal characteristics and pregnancy outcomes. Poon LC, Musci T, Song K, Syngelaki A, Nicolaides KH. Fetal Diagn Ther 2013; 33: 215-223.
196
Maternal serum activin-A at 30-33 weeks in the prediction of preeclampsia. Lai J, Pinas A, Syngelaki A, Poon LC, Nicolaides KH. J Matern Fetal Neonatal Med 2013; 26: 733-737.
197
Maternal serum cytokines at 30-33 weeks in the prediction of preeclampsia. Mosimann B, Wagner M, Poon LC, Bansal AS, Nicolaides KH. Prenatal Diagnosis 2013; 33: 823-830.
198
Maternal Serum Placental Growth Factor, Pregnancy-Associated Plasma Protein-A and Free -Human Chorionic Gonadotrophin at 30-33 Weeks in the Prediction of Pre-Eclampsia. Laiƒ J, Pinas A, Poon LC, Agathokleous M,ƒ Nicolaidesƒ KH. Fetal Diagn Ther 2013; 33: 164-172.
199
Maternal serum retinol-binding protein-4 at 11-13 weeks gestation in normal and pathological pregnancies. Nanda S, Nikoletakis G, Markova D, Poon LC, Nicolaides KH. Metabolism 2013; 62: 814-819.
200
Maternal serum soluble endoglin (sEng) at 30-33 weeks in the prediction of preeclampsia. Lai J, Syngelaki A, Poon LC, Nucci M, Nicolaides KH. Fetal Diagn Ther 2013; 33: 149-155.
201
Maternal serum tumour necrosis factor receptor 1 (TNF-R1) at 30-33 weeks in the prediction of preeclampsia. Mosimann B,ƒ Wagner M,ƒ Birdir C,ƒ Poonƒ LC,ƒ Nicolaidesƒ KH. J Matern Fetal Neonatal Med 2013; 26: 763-767.
202
Maternal thyroid function at 11-13 weeks gestation in twin pregnancy. Ashoor G, Muto O, Poon LC, Abdulla M, Nicolaides KH. Thyroid 2013; 23: 1165-1171.
203
Mean arterial pressure, systolic and diastolic blood pressure at 30-33 weeks in the prediction of preeclampsia. Lai J, Poon LC, Bakalis S, Markova D, Nicolaides KH. Fetal Diagn Ther 2013; 33: 173-181.
204
Meta-analysis of second-trimester markers for trisomy 21. Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH. Ultrasound Obstet Gynecol 2013; 41: 247-261.
205
Natural killer cells and their activation status in normal pregnancy. Mosimann B, Wagner M, Shehata H, Poon LC, Ford B, Nicolaides KH, Bansal AS. International Journal of Reproductive Medicine 2013; 2013: 906813.
206
Prediction of preeclampsia by uterine artery Doppler at 20-24 weeks™ gestation. Gallo D, Poon LC, Akolekar R, Syngelaki A, Nicolaides KH. Fetal Diagn Ther 2013; 1: 241-247.
207
Prediction of preeclampsia by uterine artery Doppler at 20-24 weeks_x0099_ gestation. Gallo D, Poon LC, Akolekar R, Syngelaki A, Nicolaides KH. Fetal Diagn Ther 2013; 1: 241-247.
208
Second-trimester screening for trisomy 21 using prefrontal space ratio. Chaveeva P, Agathokleous M, Poon LC, Markova D, Nicolaides KH. Fetal Diagn Ther 2013; 34: 50-55.
209
Second-trimester uterine artery Doppler in the prediction of stillbirths. Poon LC, Volpe N, Muto B, Yu CKH, Syngelaki A, Nicolaides KH. Fetal Diagn Ther 2013; 33: 28-35.
210
Trichorionic and dichorionic triplet pregnancies at 10-14 weeks: Outcome after embryo reduction compared to expectant management. Chaveeva P, Kosinski P, Puglia D, Poon L, Nicolaides K. Fetal Diagn Ther 2013; 1: 199-205.
211
A competing risks model in early screening for preeclampsia. Wright D, Akolekar R, Syngelaki A, Poon LC, Nicolaides KH. Fetal Diagn Ther 2012; 32: 171-178.
212
Birthweight with gestation and maternal characteristics in live births and stillbirths. Poon LC, Volpe N, Muto B, Syngelaki A, Nicolaides KH. Fetal Diagn Ther 2012; 32: 156-165.
213
C-reactive protein at 11 to 13 weeks™ gestation in spontaneous early preterm delivery. Bakalis S, Poon LC, Vayna AM, Pafilis I, Nicolaides KH. J Matern Fetal Neonatal Med 2012; 25: 2475-2478.
214
C-reactive protein at 11 to 13 weeks_x0099_ gestation in spontaneous early preterm delivery. Bakalis S, Poon LC, Vayna AM, Pafilis I, Nicolaides KH. J Matern Fetal Neonatal Med 2012; 25: 2475-2478.
215
First trimester screening for neural tube defects using AFP. Bredaki FE, Poon LC, Birdir C, Escalante D, Nicolaides KH. Fetal Diagn Ther 2012; 31: 109-114.
216
First trimester screening for spontaneous preterm delivery with maternal characteristics and cervical length. Greco E, Gupta R, Syngelaki A, Poon LC, Nicolaides KH. Fetal Diagn Ther 2012; 31: 154-161.
217
Large loop excision of transformation zone and cervical length in the prediction of spontaneous preterm delivery. Poon LC, Savvas M, Zamblera D, Skyfta E, Nicolaides KH. BJOG 2012; 119: 692-698.
218
Maternal serum ferritin at 11 to 13 weeks gestation in spontaneous early preterm delivery. Beta J, Poon LC, Bakalis S, Mosimann B, Nicolaides KH. J Matern Fetal Neonatal Med 2012; 25:1852-1855.
219
Maternal serum resistin at 11-13 weeks gestation in normal and pathological pregnancies. Nanda S, Poon LC, Muhaisen M, Acosta IC, Nicolaides KH. Metabolism 2012; 61: 699-705.
220
Protocol for measurement of mean arterial pressure at 11-13 weeks gestation. Poon LC, Zymeri NA, Zamprakou A, Syngelaki A, Nicolaides KH. Fetal Diagn Ther 2012; 31: 42-48.
221
First-trimester prediction of macrosomia. Poon LC, Karagiannis G, Stratieva V, Syngelaki A, Nicolaides KH. Fetal Diagn Ther 2011; 29: 139-147.
222
Reference range of birth weight with gestation and first-trimester prediction of small for gestation neonates. Poon LC, Karagiannis G, Staboulidou I, Shafiei A, Nicolaides KH. Prenat Diagn 2011; 31: 58-65.
223
Systolic diastolic and mean arterial pressure at 11-13 weeks in the prediction of hypertensive disorders in pregnancy: a prospective screening study. Poon LC, Kametas NA, Valencia C, Chelemen T, Nicolaides KH. Hypertens Pregnancy 2011; 30: 93-107.
224
Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks. Poon LC, Stratieva V, Piras S, Piri S, Nicolaides KH. Prenat Diagn 2010; 30: 216-223.
225
Hypertensive disorders in pregnancy: Screening by biophysical and biochemical markers at 11-13 weeks. Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH. Ultrasound in Obstetrics and Gynecology 2010; 35: 662-670.
226
Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. Poon LC, Kametas NA, Chelemen T, Leal A, Nicolaides KH. J Hum Hypertens 2010; 24: 104-110.
227
Normal ranges of embryonic length, embryonic heart rate, gestational sac diameter and yolk sac diameter in early pregnancy. Papaioannou GKI, Syngelaki A, Poon LC, Ross J, Nicolaides KH. Fetal Diagn Ther 2010; 28: 207-219.
228
First trimester urinary placental growth factor and development of pre-eclampsia. Savvidou M, Akolekar R, Zaragoza E, Poon L, Nicolaides KH. BJOG 2009; 116: 643-647.
229
First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome. Poon LC, Nekrasova E, Anastassopoulos P, Livanos P, Nicolaides KH. Prenatal Diagnosis 2009; 29: 553-559.
230
First-trimester maternal serum PAPP-A and preeclampsia. Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. Ultrasound in Obstetrics and Gynecology 2009; 33: 23-33.
231
First-trimester maternal serum tumor necrosis factor receptor-1 (TNF-R1) and preeclampsia. Leal AM, Poon LC, Frisova V, Veduta A, Nicolaides KH. Ultrasound in Obstetrics and Gynecology 2009; 33: 135-141.
232
First-trimester prediction of hypertensive disorders in pregnancy. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. Hypertension 2009; 53: 812-818.
233
Hypertensive disorders in pregnancy: Screening by uterine artery Doppler and blood pressure at 11-13 weeks. Poon LC, Karagiannis G, Leal A, Romero Infante X, Nicolaides KH. Ultrasound in Obstetrics and Gynecology 2009; 34: 497-502.
234
Hypertensive disorders in pregnancy: Screening by uterine artery Doppler at 11-13 weeks. Poon LC, Staboulidou I, Maiz N, Plasencia W, Nicolaides KH. Ultrasound in Obstetrics and Gynecology 2009; 34: 142-148.
235
Maternal serum ADAM12 (A Disintegrin And Metalloprotease) in chromosomally abnormal pregnancies at 11+0-13+6 weeks. Poon LC, Chelemen T, Minekawa R, Frisova V, Nicolaides KH. American Journal Obstetrics and Gynecology 2009; 200: 508.e1-6.
236
Maternal serum placental growth factor (plgf) at 11+0-13+6 weeks in chromosomally abnormal pregnancies. Zaragoza E, Akolekar R, Poon LC, Pepes S, Nicolaides KH. Ultrasound in Obstetrics and Gynecology 2009; 33: 382-386.
237
Blood pressure levels correlate with intra-individual variability using an automated device in early pregnancy. Poon LC, Kametas N, Valencia CM, Pandeva IV, Nicolaides KH. J Hum Hypertens 2008; 22: 438-440.
238
Fetal Medicine Foundation Prolonged Pregnancy Group. Cervical length and maternal factors in expectantly managed prolonged pregnancy: prediction of onset of labor and mode of delivery. Rao A, Celik E, Poggi S, Poon L, Nicolaides KH; Ultrasound Obstet Gynecol 2008; 32: 646-651.
239
First trimester maternal serum A Disintegrin And Metalloprotease 12 and adverse pregnancy outcome. Poon LC, Chelemen T, Granvillano O, Pandeva I, Nicolaides KH. Obstetric Gynecol 2008; 112: 1082-1090.
240
Inter-arm blood pressure differences in pregnant women. Poon LC, Kametas N, Strobl I, Pachoumi C, Nicolaides KH. BJOG 2008; 115: 1122-1130.
241
Maternal serum placental growth factor (plgf) at 11+0 to 13+6 weeks of gestation in hypertensive disorders of pregnancy. Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH. Ultrasound in Obstetrics and Gynecology 2008; 32: 732-739.
242
Maternal serum placental growth factor (plgf) at 11+0 to 13+6 weeks of gestation in small for gestational age pregnancy. Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH. Prenatal Diagnosis 2008; 28: 1110-1115.
243
Mean arterial pressure at 11+0-13+6 weeks in the prediction of pre-eclampsia. Poon LC, Kametas N, Pandeva IV, Valencia CM, Nicolaides KH. Hypertension 2008; 51: 1027-1033.
244
Prediction of preeclampsia by a combination of maternal history, uterine artery doppler and mean arterial pressure. Onwudiwe N, Yu CKH, Poon LC, Spiliopoulos I, Nicolaides KH. Ultrasound Obstet Gynecol 2008; 32: 877-883.
245
Urine albumin concentration and albumin-to-creatinine ratio at 11+0-13+6 weeks in the prediction of pre-eclampsia. Poon LC, Kametas N, Bonino S, Vercellotti E, Nicolaides KH. BJOG 2008; 115: 866-873.
246
Uterine artery Doppler at 11+0-13+6 weeks and 21+0-24+6 weeks in the prediction of pre-eclampsia. Plasencia W, Maiz N, Poon L, Yu C, Nicolaides KH. Ultrasound Obstet Gynecol 2008; 32: 138-146.
247
Audit of the effectiveness of cervical preparation with Dilapan prior to late second trimester (20-24 weeks) surgical termination of pregnancy. Poon LC, Parsons J. BJOG 2007; 114: 485-488.
248
Tetralogy of Fallot in the fetus in the current era. Poon LC, Huggon I, Zidere V and Allan LD. Ultrasound Obstet Gynecol 2007; 29: 625-627.